Petr Nauš

发表

Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.

Michal Hocek, P. Džubák, P. Konečný, 2014, Journal of medicinal chemistry.

Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides.

R. Pohl, Michal Hocek, T. Cihlar, 2012, Bioorganic & medicinal chemistry.

Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.

I. Pichová, R. Pohl, Michal Hocek, 2011, Journal of medicinal chemistry.

Sugar-Modified Derivatives of Cytostatic 6-(Het)aryl-7-deazapurine Nucleosides: 2′-C-Methylribonucleosides, Arabinonucleosides and 2′-Deoxy-2′-fluoroarabinonucleosides.

R. Pohl, Michal Hocek, Pavla Perlíková, 2011 .

6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents.

R. Pohl, Michal Hocek, R. Mackman, 2010, Journal of medicinal chemistry.

Synthesis of 2,6-Substituted 7-(Het)aryl-7-deazapurine Nucleobases (2,4-Disubstituted 5-(Het)aryl-pyrrolo[2,3-d]pyrimidines)

Michal Hocek, S. Smoleń, L. Slavětínská, 2017, Synthesis.

Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4'-C-methylribonucleosides.

Michal Hocek, J. Hodek, P. Džubák, 2015, Bioorganic & medicinal chemistry.

2‐Substituted 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity

I. Pichová, Michal Hocek, P. Džubák, 2015, ChemMedChem.

CycloSal‐phosphate Pronucleotides of Cytostatic 6‐(Het)aryl‐7‐deazapurine Ribonucleosides: Synthesis, Cytostatic Activity, and Inhibition of Adenosine Kinases

Helena Zábranská, I. Pichová, R. Pohl, 2010, ChemMedChem.

Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides.

M. Otto, R. Pohl, Michal Hocek, 2005, Journal of medicinal chemistry.

6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents

I. Pichová, Michal Hocek, P. Džubák, 2013 .

Cytostatic and Antiviral 6-Arylpurine Ribonucleosides IX. Synthesis and Evaluation of 6-Substituted 3-Deazapurine Ribonucleosides

Michal Hocek, M. Kuchař, Petr Nauš, 2008 .

Facile preparation of the oxetane-nucleosides.

W. Pathmasiri, J. Barman, J. Chattopadhyaya, 2005, Organic & biomolecular chemistry.

Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.

Helena Zábranská, I. Pichová, R. Pohl, 2014, Journal of medicinal chemistry.

COVALENT ANALOGUES OF DNA BASE-PAIRS AND TRIPLETS VII. + SYNTHESIS AND CYTOSTATIC ACTIVITY OF BIS(PURIN-6-YL)ACETYLENE AND -DIACETYLENE NUCLEOSIDES

Michal Hocek, I. Votruba, Petr Nauš, 2004 .

Copper-Assisted Arylation of 1-Thiosugars: Efficient Route to Triazene Substituted Arylthioglycosides

L. Lešetický, M. Štícha, S. Smrček, 2003 .

Site of protonation of nicotine and nornicotine in the gas phase: pyridine or pyrrolidine nitrogen?

M. Berthelot, J. Gal, P. Maria, 2002, Journal of the American Chemical Society.

Covalent Analogues of DNA Base‐Pairs and Triplets. Part 7. Synthesis and Cytostatic Activity of Bis(purin‐6‐yl)acetylene and ‐diacetylene Nucleosides.

Michal Hocek, I. Votruba, Petr Nauš, 2005 .

Synthesis of Fluorescent 2-Substituted 6-(Het)aryl-7-deazapurine Bases {4-(Het)aryl-pyrrolo[2,3-d]pyrimidines} by Aqueous Suzuki–Miyaura Cross-Coupling Reactions

Michal Hocek, D. Dziuba, L. Slavětínská, 2016, Synthesis.

7-(2-Thienyl)-7-Deazaadenosine (AB61), a New Potent Nucleoside Cytostatic with a Complex Mode of Action

Michal Hocek, P. Džubák, J. Hlaváč, 2016, Molecular Cancer Therapeutics.

Sugar-modified derivatives of cytostatic 7-(het)aryl-7-deazaadenosines: 2'-C-methylribonucleosides, 2'-deoxy-2'-fluoroarabinonucleosides, arabinonucleosides and 2'-deoxyribonucleosides.

R. Pohl, Michal Hocek, G. Birkuš, 2012, Bioorganic & medicinal chemistry.